As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...

Concr CEO Irina Babina and CTO Matthew Griffiths unpack how Bayesian foundation models can excel at uncertainty management to ...

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.